Compare LAMR & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAMR | ELAN |
|---|---|---|
| Founded | 1902 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3B | 12.2B |
| IPO Year | 1999 | 2018 |
| Metric | LAMR | ELAN |
|---|---|---|
| Price | $144.70 | $22.67 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 16 |
| Target Price | ★ $162.20 | $31.00 |
| AVG Volume (30 Days) | 424.7K | ★ 4.2M |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | ★ 63.92 | N/A |
| EPS | ★ 2.58 | 0.22 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $5.75 | $8.66 |
| Revenue Next Year | $3.86 | $5.29 |
| P/E Ratio | ★ $55.56 | $98.95 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $114.45 | $19.40 |
| 52 Week High | $166.33 | $27.98 |
| Indicator | LAMR | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 39.68 | 46.27 |
| Support Level | $144.11 | $21.89 |
| Resistance Level | $155.11 | $25.21 |
| Average True Range (ATR) | 2.56 | 0.72 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 37.93 | 52.49 |
Lamar Advertising Co is an outdoor advertising company that operates as a real estate investment trust. It is engaged in the outdoor advertising business, operating outdoor advertising displays and logo signs mainly near highway exits, delivering brand-name information on available gas, food, lodging, and camping services. Included in the company's logo sign business are tourism signing contracts. It also provides transit advertising services in airport terminals, on bus shelters, benches, and buses. The company manages its operations through three operating segments: Billboard, which generates maximum revenue, Logo, and Transit Advertising. Geographically, it operates in the United States and Canada.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.